Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 9;14:1087–1098. doi: 10.2147/CMAR.S352308

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Huang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

MiR-760 knockdown reverses the tumor-suppressive effect of silencing SLC9A3-AS1 in NSCLC cells. (A) A549 cell proliferation was measured by CCK-8 assay after co-transfection of si-SLC9A3-AS1 and miR-760 inhibitor. (B) A549 cell migration and invasion were measured by transwell assay after co-transfection of si-SLC9A3-AS1 and miR-760 inhibitor. (C) Calculation of A549 cells that migrated or invaded through the filter following eosin staining by transwell assay. **P< 0.01.

Abbreviations: NSCLC, non-small cell lung cancer; si-SLC9A3-AS1#1, #1 siRNAs against SLC9A3-AS1.